Literature DB >> 11767717

The interrater reliability of physical signs in patients with eating disorders.

I Tyler1, C L Birmingham.   

Abstract

OBJECTIVE: To evaluate the interrater reliability of five common signs of eating disorders.
METHODS: Eating disorder patients with anorexia nervosa, bulimia nervosa, and eating disorders not otherwise specified (ED-NOS), at various stages of recovery, were evaluated for the presence or absence of lanugo hair, acrocyanosis, parotid hypertrophy, hypercarotinemia, and Russell's sign. Patients were examined by two physicians with similar experience and training. Results are analyzed for reliability using the kappa statistic.
RESULTS: Kappa scores were as follows, indicating marginal reproducibility of results: lanugo hair (kappa = 0.606), acrocyanosis (kappa = 0.014), parotid hypertrophy (kappa = 0.266), hypercarotinemia (kappa = 0.101) , and Russell's sign (kappa = 0.140).
CONCLUSION: The interrater reliability for individual items ranged from poor to moderate. Overall, there is marginal interrater reliability for the five common signs of eating disorders assessed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11767717     DOI: 10.1002/eat.1094

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  4 in total

1.  Delayed diagnosis of familial adenomatous polyposis in an adolescent patient with a coexisting eating disorder.

Authors:  Wu Deng; Steve Sears; Susan Garand; Laurie Farricielli
Journal:  BMJ Case Rep       Date:  2013-12-11

Review 2.  Acrocyanosis: the Flying Dutchman.

Authors:  Andrew K Kurklinsky; Virginia M Miller; Thom W Rooke
Journal:  Vasc Med       Date:  2011-03-22       Impact factor: 3.239

3.  Parotid gland enlargement in eating disorders: an insensitive sign?

Authors:  C Price; M A Schmidt; E J Adam; H Lacey
Journal:  Eat Weight Disord       Date:  2008-12       Impact factor: 4.652

Review 4.  The chronic gastrointestinal manifestations of Chagas disease.

Authors:  Nilce Mitiko Matsuda; Steven M Miller; Paulo R Barbosa Evora
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.